School-based program cuts depression and anxiety in newcomer students

The first randomized control trial of the school-based intervention called Supporting Transition Resilience of Newcomer Groups (STRONG) shows significant reductions in depression, anxiety and behavior problems among refugee and immigrant students.

Study finds potential HIV cure using existing cancer drug

An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to

August 30, 2023

Shorla raises funds to advance oncology drug candidates

Shorla is involved in the development of treatments for oncology. Credit: Shorla Oncology. US-Ireland speciality pharmaceutical company Shorla Oncology has received $35m in Series B

October 5, 2023

A pricey Gilead HIV drug could be made for dramatically less than the company claims, researchers say

Following the release of widely touted study results for a Gilead Sciences HIV treatment, a new analysis finds the medicine — called lenacapavir — could

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.